Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.52 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4962691 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL3901066 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL17129695 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL3654757 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL196231 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL165539 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL167866 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL168066 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL196051 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL195599 | 1.00 | FFAR4 (0.64) | FFAR4FFAR1LMNATSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3215127-B1 | COMPOSITIONS COMPRISING CYCLOSPORIN | SUBLIMITY THERAPEUTICS LTD (IE) | 2020-10-28 | — | — | EP | claimed |
| EP-3307233-B1 | COMPOSITION COMPRISING A UV-SCREENING AGENT, AN ANIONIC CROSSLINKED HYDROPHILIC POLYMER, A SURFACTANT HAVING AN HLB LESS THAN OR EQUAL TO 5 AND A SILICONE COPOLYMER | OREAL (FR) | 2019-11-06 | — | — | EP | claimed |
| EP-2452668-B1 | EMULSIFIED COMPOSITION | KAO CORP (JP) | 2018-10-03 | — | — | EP | claimed |
| EP-2857000-B1 | EMULSION COSMETIC COMPOSITION | KAO CORP (JP) | 2016-10-05 | — | — | EP | claimed |
| EP-1689368-B1 | SPRAY-CONGEAL PROCESS USING AN EXTRUDER FOR PREPARING MULTIPARTICULATE CRYSTALLINE DRUG COMPOSITIONS | BEND RES INC (US) | 2016-09-28 | — | — | EP | claimed |
| EP-1537859-B1 | Azithromycin dosage forms with reduced side effects | PFIZER PROD INC (US) | 2008-09-10 | — | — | EP | claimed |
| EP-1521573-B1 | NON-POLYMERIC LIPOPHILIC PHARMACEUTICAL IMPLANT COMPOSITIONS FOR INTRAOCULAR USE | ALCON INC (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-0794803-B1 | DIAPER HAVING A LOTIONED TOPSHEET CONTAINING A POLYSILOXANE EMOLLIENT | PROCTER & GAMBLE (US) | 2005-12-14 | — | — | EP | claimed |
| EP-0774346-B1 | Polymeric films | TRESPAPHAN GMBH (DE) | 2003-03-19 | — | — | EP | claimed |
| EP-0971750-B1 | ABSORBENT ARTICLES HAVING LOTIONED LEG CUFFS | PROCTER & GAMBLE (US) | 2003-02-26 | — | — | EP | claimed |
| EP-0734474-B1 | LOTION COMPOSITION FOR TISSUE PAPER | PROCTER & GAMBLE (US) | 2002-06-05 | — | — | EP | claimed |
| EP-0641557-B1 | Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystal coating | OREAL (FR) | 1996-08-21 | — | — | EP | claimed |
| EP-3995135-B1 | PROLONGED RELEASE DOSAGE FORM OF TAPENTADOL L-(+)- TARTARIC ACID SALT | GRUENENTHAL GMBH (DE) | 2022-07-13 | — | — | EP | disclosed |
| WO-2022101247-A1 | SUSTAINED RELEASE DOSAGE FORMS OF A SALT OF TAPENTADOL WITH L-(+)-TARTARIC ACID | Grünenthal GmbH (DE) | 2022-05-19 | — | — | WO | disclosed |
| EP-3995135-A1 | PROLONGED RELEASE DOSAGE FORM OF TAPENTADOL L-(+)- TARTARIC ACID SALT | Grünenthal GmbH (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3192491-A1 | COMPOSITION COMPRISING POLYGLYCEROL ESTERS AND HYDROXY-ALKYL MODIFIED GUAR | Evonik Degussa GmbH (DE) | 2017-07-19 | — | — | EP | disclosed |
| US-7517545-B2 | Reduced-calorie fats containing behenic acid and process of making thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2009-04-14 | — | — | US | disclosed |
| US-20040043125-A1 | Reduced-calorie fats containing behenic acid and process for preparing same | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH, (IN) | 2004-03-04 | — | — | US | disclosed |
| US-6617141-B1 | Esterifying edible oils with 1,3-dibehenin in the presence of a thermostable lipase | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2003-09-09 | — | — | US | disclosed |